As of October 8, 2026, CBG / CBDA / CBGA (hemp-derived) is illegal to sell at retail in Ohio as flower / raw plant. Ohio SB 56: final hemp products over 0.4 mg total THC per container are marijuana, dispensary only, since Mar 20, 2026. Effective 2026-03-20. Controlling source: R.C. 928.01 (authenticated, eff. 3-20-2026).
Verified October 8, 2026 · confidence: confirmedSB 56 replaced R.C. 928.01; hemp now excludes final hemp-derived cannabinoid products with more than four-tenths of a milligram of total THC per container, and total THC includes THCa. CBD and CBG cigarettes and pre-rolls are final products, so a pack with ordinary trace THC exceeds the cap and becomes marijuana sold only at licensed dispensaries (21+). Raw flower sold as 'hemp' plant material is arguably still hemp at 0.3% total THC, but any consumer-packaged flower risks being treated as a final product; treat as prohibited outside dispensaries. Penalty: selling intoxicating hemp outside dispensaries is reported as a first-degree misdemeanor, then fifth-degree felony. Watch the federal litigation (relief so far limited to named plaintiffs). Applies to CBG pre-rolls and flower. Flags: sale ban True, manufacture-only ban False, shipping ban False, 21+ True, license True, total-THC flower test True. Pending: Federal suits against SB 56 produced plaintiff-specific preliminary injunctions (Apr, Jun, Jul 2026); no general injunction verified. Federal: hemp redefinition limiting hemp-derived products to 0.4 mg total THC per container now takes effect 2026-12-11 (moved from 2026-11-12 by H.R. 6500, signed 2026-09-02, per Foley Hoag Sept 2026); a 0.3% total-THC pre-roll can exceed 0.4 mg per container.
Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols
As of October 8, 2026, CBG / CBDA / CBGA (hemp-derived) is legal to sell at retail with restrictions in Ohio as tincture / sublingual. Ohio: CBG/CBDA oils over 0.4 mg total THC per container are not hemp. The limit is null (mg per container). Controlling source: R.C. 928.01 (eff. 3/20/2026), authenticated.
Verified October 8, 2026 · confidence: confirmedSB 56 replaced R.C. 928.01 effective March 20, 2026: hemp is 0.3% total THC including THCA, and a final hemp-derived cannabinoid product with more than four-tenths of a milligram combined total THC per container is not hemp (marijuana, dispensary-only, 21+). 'Hemp-derived cannabinoid product' covers products for human or animal use by inhalation, ingestion or topical application, with no topical or pet carve-out. Full-spectrum CBD at 0.5 to 2 mg per container fails. Federal preliminary injunctions (latest Sept. 24 and Oct. 5, 2026, Fresh Farms) protect only named plaintiffs. Applies to CBG, CBDA and CBGA oils. Limit noted: <=0.4 mg combined total THC per container; 0.3% total THC. Pending: Federal suits produced plaintiff-specific injunctions only (Fresh Farms, Sept. 24 and Oct. 5, 2026). Federal: from 2026-12-11 the federal hemp definition excludes final hemp-derived cannabinoid products (ingested, topical or animal use) with more than 0.4 mg combined total THC per container (Pub. L. 119-37 div. B sec. 781, as delayed by Pub. L. 119-103 sec. 2019); full-spectrum CBD above 0.4 mg per container becomes marijuana federally in every state.
Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols
As of October 8, 2026, CBG / CBDA / CBGA (hemp-derived) is legal to sell at retail with restrictions in Ohio as edible / ingestible. Ohio: CBG gummies and drinks over 0.4 mg total THC per container are not hemp. The limit is null (mg per container). Controlling source: R.C. 928.01 (eff. 3/20/2026), authenticated.
Verified October 8, 2026 · confidence: confirmedSB 56 replaced R.C. 928.01 effective March 20, 2026: hemp is 0.3% total THC including THCA, and a final hemp-derived cannabinoid product with more than four-tenths of a milligram combined total THC per container is not hemp (marijuana, dispensary-only, 21+). 'Hemp-derived cannabinoid product' covers products for human or animal use by inhalation, ingestion or topical application, with no topical or pet carve-out. Full-spectrum CBD at 0.5 to 2 mg per container fails. Federal preliminary injunctions (latest Sept. 24 and Oct. 5, 2026, Fresh Farms) protect only named plaintiffs. Applies to CBG gummies, CBG drinks and water-soluble CBG (CBGo). Limit noted: <=0.4 mg combined total THC per container; 0.3% total THC. Pending: Federal suits produced plaintiff-specific injunctions only (Fresh Farms, Sept. 24 and Oct. 5, 2026). Federal: from 2026-12-11 the federal hemp definition excludes final hemp-derived cannabinoid products (ingested, topical or animal use) with more than 0.4 mg combined total THC per container (Pub. L. 119-37 div. B sec. 781, as delayed by Pub. L. 119-103 sec. 2019); full-spectrum CBD above 0.4 mg per container becomes marijuana federally in every state.
Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols
As of October 8, 2026, CBG / CBDA / CBGA (hemp-derived) is legal to sell at retail with restrictions in Ohio as raw material / ruo. Ohio: Buyer needs an ODA hemp processing license; our extract must meet Ohio testing rules and 0.3% total THC. Controlling source: R.C. 928.01 Definitions (eff. 3/20/2026), authenticated PDF.
Verified October 8, 2026 · confidence: confirmed(2) An entity residing in a jurisdiction where the extracted cannabinoids have been extracted and tested in accordance with rule 901:14-2-12 to rule 901:14-2-15 of the Administrative Code.
| Form | Status | Headline | Verified |
|---|---|---|---|
| Flower / raw plant | Illegal | Ohio SB 56: final hemp products over 0.4 mg total THC per container are marijuana, dispensary only, since Mar 20, 2026. | 2026-10-08 |
| Tincture / sublingual | Restricted | Ohio: CBG/CBDA oils over 0.4 mg total THC per container are not hemp. | 2026-10-08 |
| Edible / ingestible | Restricted | Ohio: CBG gummies and drinks over 0.4 mg total THC per container are not hemp. | 2026-10-08 |
| Raw material / RUO | Restricted | Ohio: Buyer needs an ODA hemp processing license; our extract must meet Ohio testing rules and 0.3% total THC. | 2026-10-08 |
Among Ohio's 5 neighbors, Indiana and Kentucky are illegal; West Virginia is restricted; Michigan is gray area; Pennsylvania is legal.
Map and neighbor comparison show flower / raw plant. Open the interactive map · Every compound in Ohio
Federally restricted. Hemp today; from Dec 11, 2026 a pre-roll or cigarette over 0.4 mg total THC per container leaves hemp (Schedule I) Federal detail
4 instruments on file for this compound's framework in Ohio; 13 of 16 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
6c140edf84af933dAs used in this chapter: (A) "Container" means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge. "Container" does not include bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use. (C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (E) "Hemp-derived cannabinoid product" means any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form and is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application. "Hemp-derived cannabinoid product" does not include a drug that is the subject of an application approved under subsection (c) or (j) of 21 U.S.C. 355. (H) "Intermediate hemp-derived cannabinoid product" means a hemp-derived cannabinoid product that is either of the following: (1) Not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; (2) A powder, liquid, tablet, oil, or other product form that is intended or marketed to be mixed, dissolved, formulated, or otherwise added to or prepared with or into any other substance prior to administration or consumption.
6c140edf84af933dAs used in this chapter: (A) "Container" means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge. "Container" does not include bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use. (C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (E) "Hemp-derived cannabinoid product" means any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form and is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application. "Hemp-derived cannabinoid product" does not include a drug that is the subject of an application approved under subsection (c) or (j) of 21 U.S.C. 355. (H) "Intermediate hemp-derived cannabinoid product" means a hemp-derived cannabinoid product that is either of the following: (1) Not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; (2) A powder, liquid, tablet, oil, or other product form that is intended or marketed to be mixed, dissolved, formulated, or otherwise added to or prepared with or into any other substance prior to administration or consumption.
eda464f28d51571e(C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code.
5ca11dce0915c0e2928.01 (C) "'Hemp' means the plant Cannabis sativa L. and any part of that plant" [...] [with a total THC concentration] "of not more than three-tenths per cent on a dry weight basis" [where total THC means] "total tetrahydrocannabinols, including tetrahydrocannabinolic acid". (C)(4) [Hemp does not include final hemp-derived cannabinoid products containing:] (a) "Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant" [...] (c) "Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols" [...]. (E) ["Hemp-derived cannabinoid product" means] "any intermediate or final product derived from hemp, other than industrial hemp" [intended for human or animal use by means] "such as inhalation, ingestion, or topical application". [Bracketed spans summarized; authenticated PDF dated 3-20-2026.]
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap